J M Grassi - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Journal of Psychopharmacology (Oxford, England)|October 8, 1999

In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administrationJ M Fahey, G A Pritchard, J M Grassi, et al.

Pharmacology, Biochemistry, and Behavior|June 23, 2001

Pharmacodynamic and receptor binding changes during chronic lorazepam administrationJ M Fahey, G A Pritchard, J M Grassi, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998

Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in miceJ M Fahey, G A Pritchard, L L Moltke, et al.

Psychopharmacology|August 13, 1999

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actionsL L von Moltke, D J Greenblatt, B W Granda, et al.

The Journal of Pharmacy and Pharmacology|November 12, 1998

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3AL L von Moltke, D J Greenblatt, J M Grassi, et al.

British Journal of Clinical Pharmacology|June 26, 1999

Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlationsL L Von Moltke, D J Greenblatt, B W Granda, et al.

Journal of Clinical Psychopharmacology|August 5, 1998

Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermineL L von Moltke, D J Greenblatt, D A Ciraulo, et al.

Biological Psychiatry|September 24, 1999

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.

Journal of Clinical Pharmacology|April 29, 1998

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavirL L von Moltke, D J Greenblatt, J M Grassi, et al.

Psychopharmacology|January 7, 1999

Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Journal of Psychopharmacology (Oxford, England)|October 8, 1999

In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administrationJ M Fahey, G A Pritchard, J M Grassi, et al.

Pharmacology, Biochemistry, and Behavior|June 23, 2001

Pharmacodynamic and receptor binding changes during chronic lorazepam administrationJ M Fahey, G A Pritchard, J M Grassi, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998

Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in miceJ M Fahey, G A Pritchard, L L Moltke, et al.

Psychopharmacology|August 13, 1999

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actionsL L von Moltke, D J Greenblatt, B W Granda, et al.

The Journal of Pharmacy and Pharmacology|November 12, 1998

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3AL L von Moltke, D J Greenblatt, J M Grassi, et al.

British Journal of Clinical Pharmacology|June 26, 1999

Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlationsL L Von Moltke, D J Greenblatt, B W Granda, et al.

Journal of Clinical Psychopharmacology|August 5, 1998

Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermineL L von Moltke, D J Greenblatt, D A Ciraulo, et al.

Biological Psychiatry|September 24, 1999

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.

Journal of Clinical Pharmacology|April 29, 1998

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavirL L von Moltke, D J Greenblatt, J M Grassi, et al.

Psychopharmacology|January 7, 1999

Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.

Pageof 1